Sustained virological response of pegylated interferon α-2A plus ribavirin in patients with chronic hepatitis C genotype 4

被引：0
|
作者：
Shiha, G
Gabre, M
Zalata, K
Sayed, S
机构：
[1] Mansoura Univ, Fac Med, Dept Internal Med, Mansoura, Egypt
[2] Mansoura Univ, Dept Pathol, Mansoura, Egypt
[3] Tanta Univ, Fac Med, Dept Internal Med, Tanta, Egypt
来源：
GUT | 2004年 / 53卷
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
316
引用
收藏
页码：A81 / A81
页数：1
相关论文
共 50 条
  • [1] Hydroxychloroquine augments early virological response to pegylated interferon plus ribavirin in genotype-4 chronic hepatitis C patients
    Helal, Gouda Kamel
    Gad, Magdy Abdelmawgoud
    Abd-Ellah, Mohamed Fahmy
    Eid, Mahmoud Saied
    JOURNAL OF MEDICAL VIROLOGY, 2016, 88 (12) : 2170 - 2178
  • [2] PREDICTORS OF SUSTAINED VIROLOGICAL RESPONSE IN PATIENTS WITH CHRONIC HEPATITIS C TREATED WITH PEGYLATED INTERFERON AND RIBAVIRIN
    Paci, M.
    Lorefice, E.
    Gianni, E.
    Renzo, S.
    Capanni, M.
    Forte, P.
    Milani, S.
    Surrenti, C.
    DIGESTIVE AND LIVER DISEASE, 2008, 40 : S113 - S113
  • [3] Impact of Vitamin D Supplementation on Sustained Virological Response in Chronic Hepatitis C Genotype 4 Patients Treated by Pegylated Interferon/Ribavirin
    Esmat, Gamal
    El Raziky, Maissa
    Elsharkawy, Aisha
    Sabry, Dina
    Hassany, Mohamed
    Ahmed, Amal
    Assem, Noha
    El Kassas, Mohamad
    Doss, Wahid
    JOURNAL OF INTERFERON AND CYTOKINE RESEARCH, 2015, 35 (01): : 49 - 54
  • [4] Prediction of Sustained Virological Response to Combination Therapy with Pegylated Interferon Alfa and Ribavirin in Patients with Genotype 3 Chronic Hepatitis C
    S. K. Tohra
    S. Taneja
    S. Ghosh
    B. K. Sharma
    A. Duseja
    R. K. Dhiman
    A. Das
    Y. K. Chawla
    Digestive Diseases and Sciences, 2011, 56
  • [5] Prediction of Sustained Virological Response to Combination Therapy with Pegylated Interferon Alfa and Ribavirin in Patients with Genotype 3 Chronic Hepatitis C
    Tohra, S. K.
    Taneja, S.
    Ghosh, S.
    Sharma, B. K.
    Duseja, A.
    Dhiman, R. K.
    Das, A.
    Chawla, Y. K.
    DIGESTIVE DISEASES AND SCIENCES, 2011, 56 (08) : 2449 - 2455
  • [6] Impact of ribavirin plasma level on sustained virological response in patients treated with pegylated interferon and ribavirin for chronic hepatitis C
    Breilh, D.
    Foucher, J.
    Castera, L.
    Trimoulet, P.
    Djabarouti, S.
    Merrouche, W.
    Couzigou, P.
    Saux, M. -C.
    De Ledinghen, V.
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2009, 30 (05) : 487 - 494
  • [7] Predictive factors of response to pegylated interferon α-2a and ribavirin in chronic hepatitis C Egyptian patients with genotype 4 not responding previously to standard interferon and ribavirin
    El Khayat, H.
    Maher, M.
    Ismail, A.
    Gabr, M.
    Salama, H.
    LIVER INTERNATIONAL, 2006, 26 : 17 - 18
  • [8] Insulin resistance, fibrosis and genotype are predictors of sustained response rate to pegylated interferon plus ribavirin in patients with chronic hepatitis C
    Romero-Gomez, M
    Viloria, MM
    Corpas, R
    Cruz, M
    Sanchez-Munoz, D
    Grande, L
    Castillo, J
    Suarez, E
    Camacho, I
    Nogales, MC
    JOURNAL OF HEPATOLOGY, 2004, 40 : 150 - 150
  • [9] Sustained virological response of peginterferon U-2A plus ribavirin for chronic hepatitis C virus genotype 4
    Shiba, G.
    Khalek, F. Abdel
    Abbas, B.
    Elshennawy, H.
    Zalata, K. H.
    JOURNAL OF HEPATOLOGY, 2007, 46 : S215 - S215
  • [10] The predictors of sustained virological response with sofosbuvir and ribavirin in patients with chronic hepatitis C genotype 2
    Han, Sung Yong
    Woo, Hyun Young
    Heo, Jeong
    Park, Sang Gyu
    Pyeon, Sung Ik
    Park, Young Joo
    Kim, Dong Uk
    Kim, Gwang Ha
    Kim, Hyung Hoi
    Song, Geun Am
    Cho, Mong
    KOREAN JOURNAL OF INTERNAL MEDICINE, 2021, 36 (03): : 544 - +
12345